A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children

Clinical trial NCT00113490 · COMPLETED

Trial details

NCT number: NCT00113490
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Motavizumab Administration for a Second Season for RSV Prophylaxis

Start date: 2005-05-01
Primary completion: 2006-02-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.